New trial to boost childhood brain cancer survival rates

Published: 7 May 2018

With three children and adolescents dying from cancer every week in Australia, the NSW Government has invested a further $1 million into childhood cancer research.

The latest funding will support Zero Childhood Cancer program’s launch of INFORM 2, an immunotherapy trial.

The trial aims to find new treatments that boost survival rates of childhood brain cancer.

Jointly run by the Children’s Cancer Institute and the Sydney Children’s Hospitals Network, the Zero Childhood Cancer program already offers Australia’s first ever personalised medicine program for children with high-risk or relapsed cancer.

The Zero Childhood Cancer program is also working with the Australian Government’s $100 million Australian Brain Cancer Mission to double survival rates for people with brain cancer and improve their quality of life.

This latest investment by the NSW Government follows its joint $41 million ProCan announcement in April 2018 with the Australian Government to expand cancer research.

Health Minister Brad Hazzard said the $1 million will support life-saving work carried out by the Zero Childhood Cancer program, and builds on the $5.63 million awarded by the NSW Government to the program in 2015.

“Sadly, cancer kills more children than any other disease. Every child death is a tragedy and is absolutely devastating for the entire family,” Mr Hazzard said.

“We want to do all we can to help these children beat brain cancer and live longer.”

Learn more about the Zero Childhood Cancer program

Top of page